Radiotherapy. used to treat only small areas that are causing particular problems.

Similar documents
Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

This Infosheet explains what Monoclonal Gammopathy of Undetermined Significance (MGUS) is and how it is diagnosed and managed.

Immunotherapy in myeloma

Daratumumab (Darzalex )

Information and resources for African Americans living with multiple myeloma and their caregivers

Myeloma Bone Disease and Bisphosphonates. Myeloma Infoguide Series.

Myeloma An Introduction. Myeloma Infoguide Series. Essentials

This talk will cover. Treatment for relapsed and/or refractory myeloma. What is relapsed myeloma and refractory myeloma. Treatment options for relapse

Patient and Family Myeloma Infoday

Myeloma bone disease and bisphosphonates Myeloma Infoguide Series

Myeloma. Your Essential Guide

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE

Treatment strategies for relapsing and refractory myeloma

Myeloma treatment algorithm 1999

Myeloma Bone Disease Current and Future Treatment. A Publication of The Bone and Cancer Foundation

This talk will cover. New insights and future directions. Dr Hannah Hunter Consultant Haematologist University Hospitals Plymouth NHS Trust

Health technology assessment

Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust. Natural course of myeloma. Some definitions. First relapse.

CAREGIVER GUIDE themmrf.org

Infopack for relapsed and/or refractory myeloma patients. Infoline:

The Myeloma Guide Information for Patients and Caregivers

Leading Voices. Jonathan Montgomery, Chair of the Health Research Authority (HRA) Patient Experience David Corrin My Myeloma Story

Advance Directives (Living Wills) Scotland

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng35

07/30/2013. Record of Revisions IRB Page 1 of 17

Treatment strategies for relapsing and refractory myeloma

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org

Job Description. Marketing & Content Manager. Marketing and Communications. Head of Marketing and Communications

Insertion of Skin Tunnelled Central Venous Catheter (STC)

MULTIPLE MYELOMA. A Patients Guide

Stem cells and motor neurone disease

Stem Cells Canadian Perspective

Strategies for Adaptive RT

Living well with myeloma Your Essential Guide Myeloma Infoguide Series

Patient Handbook on Stem Cell Therapies

Leukemia / Bone Marrow Transplant (BMT) Program of British Columbia

Living well with myeloma Your Essential Guide Myeloma Infoguide Series

Information for Workers

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way.

Panobinostat (Farydak ) and myeloma Myeloma Infoguide Series

Welcome Back to the Framingham Heart Study

Myocardial Perfusion (MIBI) scan

Telephone Banking for business. Fast and secure banking at the end of the phone

COMMERCIALISM INTEGRITY STEWARDSHIP. Policy and procedure on flexitime system

Related Donor Informed Consent to Participate in Research

RADIATION LEVEL IN CHINA AND PROTECTION STANDARDS

Nottingham Saturday 11 March 2017 PROGRAMME. #myelomainfodays

Ingenia MR-RT. MR Systems. The comprehensive MR-sim solution to fit your planning

Introduction This is an exam style question on stem cells that might be useful towards the end of the topic.

International Myeloma Foundation Myeloma Action Month Proclamation Kit

Genentech, Inc., its research partners, collaborators, assignees, licensees or designees. Invitation to Participate

Improve Patient Satisfaction Through Employee Rounding. Tracking & Improving Employee Satisfaction Scores

Optimizing Adaptive Workflows Using RapidPlan at the Beatson West of Scotland Cancer Centre

Stem cell dialogue: key findings, conclusions and recommendations. Dr Darren Bhattachary, Director BMRB

UNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS Cambridge International Level 3 Pre-U Certificate Principal Subject

OCCUPATIONAL HEALTH. Manager s Guide for Occupational Health

Patient Case and Question

PROTECT YOURSELF PROTECT YOUR FAMILY PROTECT YOUR COMMUNITY from Ebola

Nuclear Power Plant Incidents

Ask your surgeon for more information about Natrelle and visit GummyImplants.com

What is the purpose of the Tissue Bank and the Research it will be used for?

The King s Liver Research Tissue Bank

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

MRI-Guided On-line Adaptive Radiotherapy The UCLA Physics Experience. Disclosures 8/3/2016

Cash account. Current accounts

Treatment options in Myeloma. BritModis myeloma for the elderly care specialist

Management of Multiple Myeloma: The Changing Paradigm

Treatment: Nutrition and Medication

Cardiac Rhythm Management // Patient Brochure // BioMonitor 2. BioMonitor 2. Patient Information

Complaints Handling Procedure A Guide for Students

Enoxaparin (Lovenox )

Denosumab for the prevention of skeletal related events in patients with multiple myeloma first line

Employers obligations and Employee entitlements when using Display Screen Equipment in Ireland

Participant Information

Comments & Complaints How to comment or complain about a Council service

From Stem Cell to Any Cell

To learn more about the MMRF, visit or call Accredited by: 2015 Multiple Myeloma Reseach Foundation

Serum Free Light Chain Assay. Myeloma Infoguide Series

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

Package leaflet: Information for the user. HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion. Human albumin

Fluoroscopy units come in many different physical configurations but all consist of the main components shown in this slide.

Dana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse

AVONEX. What is in this Leaflet. What AVONEX is used for. Before you use AVONEX. Interferon beta-1a. Consumer Medicine Information

INFECTION CONTROL ISSUES IN CONSTRUCTION AND RENOVATION

Supporter Care Assistant RECRUITMENT PACK - November 2017

An Taoiseach Opens New Research Centres to Benefit Frontline Patient Care

8/2/2011. Elements of a Process Flow Trying use good planning to eliminate iterations. Thanks for contributions to this talk from

R/F. Experiences Using SONIALVISION safire and the Utility of Tomosynthesis. 1. Introduction. 2. Basics of Tomosynthesis.

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)

ABO Typing Discrepancies

INJURED WORKERS. Handbook

Delivery uncertainties and their consequences

THE PRECISE ANSWER TO STEREOTACTIC RADIATION THERAPY

Transcription:

Radiotherapy This Infosheet explains what radiotherapy is, how it is used in the treatment of myeloma, how it is given and what the possible side-effects of this treatment are. What is radiotherapy? Radiotherapy is the use of highenergy radiation (usually X-rays) to kill cancer cells. It works by targeting cells that are multiplying rapidly (such as myeloma cells) and damaging them so they cannot reproduce and grow. Radiotherapy is a very useful treatment for myeloma, but, because it also damages normal bone marrow cells, it is usually Myeloma Infosheet Series Treatments and tests used to treat only small areas that are causing particular problems. How is radiotherapy used to treat myeloma? Myeloma bone disease is a common feature of myeloma and bone pain is a very common symptom. Myeloma bone disease occurs because the myeloma cells in the bone marrow can affect the surrounding bone and cause it to thin. Myeloma bone disease can be very painful. Infoline: 0800 980 3332 1

Radiotherapy can be used to kill myeloma cells and to relieve pain in areas where there is damage caused by myeloma bone disease. Radiotherapy can often relieve pain more quickly than anti-myeloma and/or pain-killing medication, and may sometimes be the initial treatment given, but it is generally used to address reasonably localised damage. Radiotherapy can be used to: Relieve pain and kill myeloma cells in a particular area of bone Relieve pressure on the spinal cord if myeloma cells grow and expand out of the bone marrow causing spinal cord compression, or if the bones of the spine (vertebrae) collapse due to myeloma bone disease Control or prevent the return of a solitary plasmacytoma. A solitary plasmacytoma is an accumulation of myeloma cells with no evidence of myeloma elsewhere in the body To reduce the number of myeloma cells prior to an allogeneic stem cell transplant (using donor stem cells) What does radiotherapy involve? Radiotherapy is a treatment that requires specialist staff and equipment, and is carried out in the radiotherapy department of larger hospitals. This means that it is sometimes necessary to travel to another hospital for treatment. Radiotherapy is usually given as an outpatient, unless you are already in hospital for other treatment. Radiotherapy is given using a large machine positioned exactly over the area of the body to be treated. Radiotherapy treatment needs to be carefully planned to make sure the targeted area receives the correct dose of radiation while normal body tissues are as unaffected as possible. Normal X-rays, CT scanning or MRI imaging can be used to define the area to be treated. The area is then marked using a special pen to guide the treatment. Receiving radiotherapy is very similar to having an X-ray. The radiation beam is invisible but the machine may move and make a noise. 2 www.myeloma.org.uk

Radiotherapy is a painless procedure and only lasts for a few minutes, sometimes only seconds. It is important to remain still and breathe normally. Treatments are referred to as fractions and you might only need one or two to relieve the pain at any particular site. An improvement is normally noticeable within days. What are the potential side-effects? Side-effects vary from patient to patient, but are almost always temporary and fade after treatment is finished. Usually any side-effects will have completely gone 2-3 weeks after treatment has been stopped. Most patients have no problems at all. Some of the more common potential side-effects may include: Sensitivity of skin: The skin can become sensitive at the site of administration (described as being similar to sunburn). Excessive washing, friction or heat should be avoided and areas treated with radiotherapy should not be exposed to the sun. Nausea: Can start within a few hours of treatment but usually only lasts 24 48 hours. It is generally only a problem if the upper abdomen or corresponding area of the back is being treated. Nausea can be treated with anti-sickness medication. Tiredness and fatigue: You may feel very tired after radiotherapy treatment. This may persist for a week or two after treatment has stopped. Diarrhoea: Treatment to the abdomen or pelvic region can cause diarrhoea, which can be treated with medication. If side-effects develop during or after radiotherapy, it is important to tell your doctor or nurse as most of these effects can be controlled with medication. The radiation does not stay in the body after treatment so patients do not become radioactive and it is safe to mix with other people. Future directions Research is continuing to try to improve radiotherapy treatments and reduce sideeffects. This includes clinical trials investigating the effects of more rapid treatment and those investigating different radiotherapy treatments for bone problems across a wide range of cancers. Infoline: 0800 980 3332 3

About this Infosheet The information in this Infosheet is not meant to replace the advice of your medical team. They are the people to ask if you have questions about your individual situation. All Myeloma UK publications are extensively reviewed by patients and healthcare professionals prior to publication. Other information available from Myeloma UK Myeloma UK has a range of Essential Guides, Infoguides and Infosheets available covering many areas of myeloma, its treatment and management. To order your free copies or to talk to one of our Myeloma Information Specialists about any aspect of myeloma, call the Myeloma Infoline: 0800 980 3332 or 1800 937 773 from Ireland The Myeloma Infoline is open from Monday to Friday, 9am to 5pm and is free to phone from anywhere in the UK and Ireland. From outside the UK and Ireland, call 0131 557 9988 (charged at normal rate). Information and support about myeloma is also available around the clock at www.myeloma.org.uk 4 www.myeloma.org.uk

Notes Infoline: 0800 980 3332 5

Notes 6 www.myeloma.org.uk

Notes Published by: Myeloma UK Publication date: August 2008 Last updated: May 2015 Review date: May 2017 Infoline: 0800 980 3332 7

Myeloma UK 22 Logie Mill, Beaverbank Business Park, Edinburgh EH7 4HG T: 0131 557 3332 E: myelomauk@myeloma.org.uk Charity No: SC 026116 Myeloma Infoline: 0800 980 3332 or 1800 937 773 from Ireland www.myeloma.org.uk 8Myeloma www.myeloma.org.uk Awareness Week 21-28 June